ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI— 510(k) K820391

Substantially Equivalent

Hoffmann-La Roche, Inc.

FDA 510(k) clearance K820391 for ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI, Substantially Equivalent on 1982-03-08. Applicant: Hoffmann-La Roche, Inc..

Clearance details

Applicant: Hoffmann-La Roche, Inc.
Product code: Code LAT
Advisory panel: Clinical Toxicology
Date received: 1982-02-10
Decision date: 1982-03-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.